Oral Mucositis (Ulcerative) Due to Radiation Clinical Trial
Official title:
The Effectiveness of Melatonin in Prevention of Radiation-induced Oral Mucositis
The main aim of this study was to evaluate the effectiveness of melatonin in prevention of radiation induced oral mucositis clinically and biochemically.
The study was designed as randomized, controlled, clinical trial. patients who were
undergoing chemoradiation were divided into two groups: Group I: was given conventional
treatment. Group II: was given melatonin therapy in combination with the conventional
treatment.
All patients were clinically evaluated at the start the radiotherapy, three weeks and six
weeks later for pain and oral mucositis severity. in addition, the total antioxidant capacity
of the melatonin was evaluated at the start of the radiotherapy and six weeks later.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01318889 -
Dexpanthenol Mouthwash to Treat Oral Mucositis
|
Phase 2 | |
Recruiting |
NCT06285591 -
Lactobacillus Reuteri Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors
|
N/A | |
Completed |
NCT04699487 -
Efficacy and Safety of CareMin650 for Prevention of Oral Mucositis in HNC Patients Starting Radiotherapy
|
N/A | |
Not yet recruiting |
NCT05664906 -
Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03387774 -
Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients
|
Phase 3 | |
Recruiting |
NCT05322421 -
Effectiveness of Topical Olive Oil in Prevention and Management of Radiation Induced Oral Mucositis
|
N/A | |
Active, not recruiting |
NCT03972527 -
Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients
|
N/A | |
Recruiting |
NCT06354712 -
Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.
|
Phase 2 |